Literature DB >> 23071855

The Ubiquitin Proteasome Pathway (UPP) in the regulation of cell cycle control and DNA damage repair and its implication in tumorigenesis.

Yaqin Tu1, Cai Chen, Junru Pan, Junfa Xu, Zhi-Guang Zhou, Cong-Yi Wang.   

Abstract

Accumulated evidence supports that the ubiquitin proteasome pathway (UPP) plays a crucial role in protein metabolism implicated in the regulation of many biological processes such as cell cycle control, DNA damage response, apoptosis, and so on. Therefore, alterations for the ubiquitin proteasome signaling or functional impairments for the ubiquitin proteasome components are involved in the etiology of many diseases, particularly in cancer development. In this minireview, we first give a brief outline for the ubiquitin proteasome pathway, we then discuss with focus for the ubiquitin proteasome pathway in the regulation of cell cycle control and DNA damage response, the relevance for the altered regulation of these signaling pathways in tumorigenesis is also reviewed. We finally assess and summarize the advancement for targeting the ubiquitin proteasome pathway in cancer therapy. A better understanding of the biological functions underlying ubiquitin regulatory mechanisms would provide us a wider prospective on cancer treatment.

Entities:  

Keywords:  DNA damage response; Ubiquitin proteasome pathway; cell cycle; tumorigenesis; ubiquitination

Mesh:

Substances:

Year:  2012        PMID: 23071855      PMCID: PMC3466981     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  83 in total

Review 1.  The 26S proteasome: a molecular machine designed for controlled proteolysis.

Authors:  D Voges; P Zwickl; W Baumeister
Journal:  Annu Rev Biochem       Date:  1999       Impact factor: 23.643

Review 2.  Ubiquitin: same molecule, different degradation pathways.

Authors:  Michael J Clague; Sylvie Urbé
Journal:  Cell       Date:  2010-11-24       Impact factor: 41.582

Review 3.  Cell cycle, proteolysis and cancer.

Authors:  Lili Yamasaki; Michele Pagano
Journal:  Curr Opin Cell Biol       Date:  2004-12       Impact factor: 8.382

Review 4.  Reactivation of p53 by inhibiting Mdm2 E3 ligase: a novel antitumor approach.

Authors:  J Di; Y Zhang; J Zheng
Journal:  Curr Cancer Drug Targets       Date:  2011-10       Impact factor: 3.428

5.  Requirement of ATM-dependent phosphorylation of brca1 in the DNA damage response to double-strand breaks.

Authors:  D Cortez; Y Wang; J Qin; S J Elledge
Journal:  Science       Date:  1999-11-05       Impact factor: 47.728

6.  Synergistic activation of p53 by inhibition of MDM2 expression and DNA damage.

Authors:  L Chen; S Agrawal; W Zhou; R Zhang; J Chen
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-06       Impact factor: 11.205

7.  SKP1 connects cell cycle regulators to the ubiquitin proteolysis machinery through a novel motif, the F-box.

Authors:  C Bai; P Sen; K Hofmann; L Ma; M Goebl; J W Harper; S J Elledge
Journal:  Cell       Date:  1996-07-26       Impact factor: 41.582

8.  Expression of the ubiquitin ligase subunit cyclin kinase subunit 1 and its relationship to S-phase kinase protein 2 and p27Kip1 in prostate cancer.

Authors:  Ma'anit Shapira; Ofer Ben-Izhak; Merav Slotky; Oleg Goldin; Shirly Lahav-Baratz; Dan D Hershko
Journal:  J Urol       Date:  2006-11       Impact factor: 7.450

9.  Defective p53 post-translational modification required for wild type p53 inactivation in malignant epithelial cells with mdm2 gene amplification.

Authors:  Chad D Knights; Yuangang Liu; Ettore Appella; Molly Kulesz-Martin
Journal:  J Biol Chem       Date:  2003-10-10       Impact factor: 5.157

10.  Enhancement of proteasome activity by a small-molecule inhibitor of USP14.

Authors:  Byung-Hoon Lee; Min Jae Lee; Soyeon Park; Dong-Chan Oh; Suzanne Elsasser; Ping-Chung Chen; Carlos Gartner; Nevena Dimova; John Hanna; Steven P Gygi; Scott M Wilson; Randall W King; Daniel Finley
Journal:  Nature       Date:  2010-09-09       Impact factor: 49.962

View more
  39 in total

1.  Manganese-Mediated Decrease in Levels of c-RET and Tyrosine Hydroxylase Expression In Vitro.

Authors:  Mayuko Y Kumasaka; Ichiro Yajima; Nobutaka Ohgami; Hiromasa Ninomiya; Machiko Iida; Xiang Li; Reina Oshino; Hiroko Tanihata; Masafumi Yoshinaga; Masashi Kato
Journal:  Neurotox Res       Date:  2017-07-20       Impact factor: 3.911

2.  Multi-output model with Box-Jenkins operators of linear indices to predict multi-target inhibitors of ubiquitin-proteasome pathway.

Authors:  Gerardo M Casañola-Martin; Huong Le-Thi-Thu; Facundo Pérez-Giménez; Yovani Marrero-Ponce; Matilde Merino-Sanjuán; Concepción Abad; Humberto González-Díaz
Journal:  Mol Divers       Date:  2015-03-10       Impact factor: 2.943

Review 3.  Nitrosothiol signaling and protein nitrosation in cell death.

Authors:  Anand Krishnan V Iyer; Yon Rojanasakul; Neelam Azad
Journal:  Nitric Oxide       Date:  2014-07-23       Impact factor: 4.427

4.  Gene expression pattern of insect fat body cells from in vitro challenge to cell line establishment.

Authors:  Huan Zhang; Qian Meng; Ping Tang; Xuan Li; Wei Zhu; Guiling Zhou; Ruihao Shu; Jihong Zhang; Qilian Qin
Journal:  In Vitro Cell Dev Biol Anim       Date:  2014-09-12       Impact factor: 2.416

Review 5.  The fine-tuning of proteolytic pathways in Alzheimer's disease.

Authors:  Valentina Cecarini; Laura Bonfili; Massimiliano Cuccioloni; Matteo Mozzicafreddo; Mauro Angeletti; Jeffrey N Keller; Anna Maria Eleuteri
Journal:  Cell Mol Life Sci       Date:  2016-04-27       Impact factor: 9.261

6.  Targeting the ubiquitin-proteasome system for cancer treatment: discovering novel inhibitors from nature and drug repurposing.

Authors:  Claire L Soave; Tracey Guerin; Jinbao Liu; Q Ping Dou
Journal:  Cancer Metastasis Rev       Date:  2017-12       Impact factor: 9.264

7.  Plasma proteasomal chymotrypsin-like activity correlates with prostate cancer progression.

Authors:  Xiangrong Deng; Ping Zhou; Xinghua Wei; Matthew Uhlman; Yurong Lin; Xuanting Lin; Sifeng Wu; Pengfei Diao; Haiqing Xie; Jinbao Liu; Keji Xie; Ping Tang
Journal:  Tumour Biol       Date:  2015-01-13

8.  Large-Scale Analysis of Breast Cancer-Related Conformational Changes in Proteins Using SILAC-SPROX.

Authors:  Fang Liu; He Meng; Michael C Fitzgerald
Journal:  J Proteome Res       Date:  2017-07-27       Impact factor: 4.466

Review 9.  Epigenetic regulation of UBE3A and roles in human neurodevelopmental disorders.

Authors:  Janine M LaSalle; Lawrence T Reiter; Stormy J Chamberlain
Journal:  Epigenomics       Date:  2015-11-20       Impact factor: 4.778

10.  NOB1 in non-small-cell lung cancer: expression profile and clinical significance.

Authors:  Kun Liu; Ming-Ming Gu; Hong-Lin Chen; Qing-Sheng You
Journal:  Pathol Oncol Res       Date:  2013-11-23       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.